# Influence of OATP1B1 and CYP2C9 Genotypes on the Pharmacokinetics of Bosentan Before and During Clarithromycin

> **NCT01425229** · — · COMPLETED · sponsor: **Gerd Mikus** · enrollment: 16 (actual)

## Conditions studied

- Drug Interactions

## Interventions

- **DRUG:** Bosentan

## Key facts

- **NCT ID:** NCT01425229
- **Lead sponsor:** Gerd Mikus
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-06
- **Primary completion:** 2012-05
- **Final completion:** 2012-12
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2017-05-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01425229

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01425229, "Influence of OATP1B1 and CYP2C9 Genotypes on the Pharmacokinetics of Bosentan Before and During Clarithromycin". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01425229. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*